Copyright
©The Author(s) 2021.
World J Gastroenterol. May 21, 2021; 27(19): 2366-2375
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2366
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2366
Table 1 Baseline data of esophageal cancer patients (n = 203)
Clinical features | n | (%) |
Gender | ||
Males | 181 | 89.16 |
Females | 22 | 10.84 |
Age | ||
< 60 yr | 94 | 46.31 |
≥ 60 yr | 109 | 53.69 |
Tumor stage | ||
II | 16 | 7.88 |
III | 98 | 48.28 |
IV | 68 | 33.50 |
Uncertain | 21 | 10.34 |
Pathologic type | ||
Squamous cell carcinoma | 192 | 94.58 |
Nonsquamous cell carcinoma | 11 | 5.42 |
Treatment | ||
Induction chemotherapy | 168 | 82.76 |
Postoperative adjuvant chemotherapy | 15 | 7.39 |
Postrelapse chemotherapy | 20 | 9.85 |
Primary tumor site | ||
Cervical | 14 | 6.90 |
Upper thoracic | 28 | 13.79 |
Middle thoracic | 77 | 37.93 |
Lower thoracic | 84 | 41.38 |
Table 2 Changes in body mass index and hematological indicators in esophageal cancer patients before and after chemotherapy [n (%)]
Item | Before chemotherapy | After chemotherapy | χ2/Z | P value |
Body mass index (kg/m2) | -2.646 | 0.008 | ||
< 18.5 | 25 (12.32) | 22 (10.84) | ||
18.5-23.9 | 103 (50.74) | 123 (60.59) | ||
> 23.9 | 75 (36.95) | 58 (28.57) | ||
Hemoglobin (g/L) | 55.710 | < 0.001 | ||
Decreased | 119 (58.62) | 182 (89.66) | ||
Normal | 84 (41.38) | 21 (10.34) | ||
Serum albumin (g/L) | 2.717 | 0.099 | ||
Decreased | 34 (16.75) | 47 (23.15) | ||
Normal | 169 (83.25) | 156 (76.85) | ||
Serum calcium (mmol/L) | 4.780 | 0.029 | ||
Decreased | 21 (10.34) | 36 (17.73) | ||
Normal | 182 (89.66) | 167 (82.27) | ||
Blood phosphorus (mmol/L) | 2.382 | 0.123 | ||
Decreased | 23 (11.33) | 13 (6.40) | ||
Normal | 180 (88.67) | 190 (93.60) |
Table 3 Vitamin concentrations in esophageal cancer patients before and after chemotherapy
Item | Before chemotherapy (Q1-Q3) median | After chemotherapy (Q1-Q3) median | Z | P value |
Vitamin A (μmol/L) | (0.561-0.980) 0.741 | (0.528-0.858) 0.678 | -3.465 | 0.001 |
Vitamin D (nmol/L) | (33.618-49.939) 41.383 | (33.235-46.473) 38.832 | -1.599 | 0.110 |
Vitamin E (μg/mL) | (10.898-11.673) 11.267 | (10.905-11.867) 11.298 | -1.678 | 0.093 |
Vitamin B9 (nmol/L) | (14.529-23.014) 18.718 | (13.859-22.037) 17.539 | -1.578 | 0.115 |
Vitamin B12 (pg/mL) | (491.023-598.303) 557.219 | (491.112-590.338) 546.789 | -0.326 | 0.745 |
Vitamin B1 (nmol/L) | (75.056-97.909) 84.070 | (75.826-93.322) 83.095 | -1.477 | 0.140 |
Vitamin C (μmol/L) | (34.324-38.543) 36.075 | (33.299-37.849) 35.259 | -3.824 | < 0.001 |
Vitamin B2 (μg/L) | (4.182-5.050) 4.501 | (4.105-4.761) 4.284 | -2.631 | 0.009 |
Vitamin B6 (nmol/L) | (29.702-33.645) 31.747 | (28.875-32.868) 31.363 | -2.351 | 0.019 |
Table 4 Vitamin deficiencies in esophageal cancer patients before and after chemotherapy, n (%)
Item | Before chemotherapy | After chemotherapy | χ2 | P value | ||
Normal | Deficiency | Normal | Deficiency | |||
Vitamin A (μmol/L) | 163 (81.50) | 37 (18.50) | 158 (79.00) | 42 (21.00) | 0.485 | 0.486 |
Vitamin D (nmol/L) | 194 (95.57) | 9 (4.43) | 191 (94.09) | 12 (5.91) | 0.235 | 0.629 |
Vitamin C (μmol/L) | 155 (76.35) | 48 (23.65) | 133 (65.52) | 70 (34.48) | 6.682 | 0.010 |
Vitamin B2 (μg/L) | 139 (68.47) | 64 (31.53) | 108 (53.20) | 95 (46.80) | 9.677 | 0.002 |
Table 5 Changes in hematological indicators in esophageal cancer patients before and after chemotherapy
Item | Before chemotherapy (mean ± SD) | After chemotherapy (mean ± SD) | t | P value |
Hemoglobin (g/L) | 130.070 ± 16.484 | 115.010 ± 14.584 | 15.342 | < 0.001 |
Total protein (g/L) | 66.572 ± 5.726 | 64.499 ± 5.528 | 5.032 | < 0.001 |
Serum albumin (g/L) | 38.880 ± 4.138 | 37.546 ± 3.719 | 4.355 | < 0.001 |
Blood calcium (mmol/L) | 2.240 ± 0.128 | 2.207 ± 0.132 | 2.835 | 0.005 |
Blood phosphorus (mmol/L) | 1.130 ± 0.200 | 1.180 ± 0.184 | -2.818 | 0.005 |
Table 6 Factors affecting various indicators in esophageal cancer patients during chemotherapy
Item | Gender (Males/females) | Age (≥ 60 yr/< 60 yr) | Tumor grades (grades II/III/IV) | Tumor location (cervical/upper, middle, lower thoracic) | ||||
F | P value | F | P value | F | P value | F | P value | |
Body mass index | 0.014 | 0.904 | 0.042 | 0.837 | 0.672 | 0.512 | 0.718 | 0.542 |
Hemoglobin | 0.044 | 0.834 | 0.757 | 0.385 | 0.747 | 0.475 | 0.195 | 0.900 |
Serum albumin | 0.707 | 0.402 | 3.387 | 0.067 | 0.210 | 0.811 | 2.554 | 0.057 |
Vitamin A | 5.407 | 0.021 | 0.059 | 0.809 | 0.151 | 0.860 | 0.692 | 0.558 |
Vitamin D | 0.594 | 0.442 | 0.326 | 0.568 | 6.899 | 0.001 | 0.324 | 0.808 |
Vitamin C | 3.774 | 0.053 | 0.537 | 0.464 | 2.633 | 0.075 | 2.261 | 0.083 |
Vitamin B2 | 0.178 | 0.674 | 0.863 | 0.354 | 0.381 | 0.684 | 2.273 | 0.081 |
Table 7 Relationships between the differences in vitamins before and after chemotherapy and the difference in body mass index before and after chemotherapy in esophageal cancer patients
Difference in vitamin concentration | Difference in BMI | |
r | P value | |
Vitamin A | 0.240 | 0.001 |
Vitamin D | -0.080 | 0.259 |
Vitamin E | -0.095 | 0.177 |
Vitamin B9 | -0.016 | 0.824 |
Vitamin B12 | -0.053 | 0.449 |
Vitamin B1 | 0.021 | 0.771 |
Vitamin C | 0.188 | 0.007 |
Vitamin B2 | -0.102 | 0.149 |
Vitamin B6 | -0.078 | 0.269 |
Table 8 Regression analysis of the relationships between the concentrations of various vitamins and body mass index in 203 esophageal cancer patients
Independent variables (differences) | Dependent variable (difference in BMI) | ||
B (coefficient) | t | P value | |
Constant | 0.365 | 4.978 | < 0.001 |
Vitamin A | 0.304 | 1.877 | 0.062 |
Vitamin D | -0.009 | -2.355 | 0.020 |
Vitamin C | 0.026 | 1.793 | 0.074 |
- Citation: Liang LQ, Meng LL, Cai BN, Cui ZP, Ma N, Du LH, Yu W, Qu BL, Feng SQ, Liu F. Changes in the nutritional status of nine vitamins in patients with esophageal cancer during chemotherapy. World J Gastroenterol 2021; 27(19): 2366-2375
- URL: https://www.wjgnet.com/1007-9327/full/v27/i19/2366.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i19.2366